Detalhe da pesquisa
1.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood
; 111(9): 4477-89, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18285545